Acasti Pharma Inc logo

Acasti Pharma Inc - Class A

NAS:ACST (Canada)   Class A
$ 2.87 -0.2 (-6.51%) 10:08 PM EST
At Loss
P/B:
0.42
Market Cap:
$ 26.98M
Enterprise V:
$ 3.77M
Volume:
19.74K
Avg Vol (2M):
28.14K
Also Trade In:
Volume:
19.74K
At Loss
Avg Vol (2M):
28.14K

Business Description

Acasti Pharma Inc logo
Acasti Pharma Inc
NAICS : 325412 SIC : 3741
ISIN : CA00430K4028

Share Class Description:

ACST: Class A
Description
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.
Name Current Vs Industry Vs History
Cash-To-Debt 1046.42
Equity-to-Asset 0.85
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 1.39
9-Day RSI 6.68
14-Day RSI 18.07
6-1 Month Momentum % 36.55
12-1 Month Momentum % 20.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.19
Quick Ratio 15.19
Cash Ratio 14.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -58.2
Shareholder Yield % -24.13
Name Current Vs Industry Vs History
ROE % -53.84
ROA % -45.79
ROIC % -17.36
ROC (Joel Greenblatt) % -4341.47
ROCE % -14.91

Financials (Next Earnings Date:2024-06-21 Est.)

ACST's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ACST

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Acasti Pharma Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -4.578
Beta 0.64
Volatility % 73.68
14-Day RSI 18.07
14-Day ATR ($) 0.121024
20-Day SMA ($) 3.346995
12-1 Month Momentum % 20.44
52-Week Range ($) 1.72 - 3.839999
Shares Outstanding (Mil) 9.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Acasti Pharma Inc Filings

Filing Date Document Date Form
No Filing Data

Acasti Pharma Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Acasti Pharma Inc Frequently Asked Questions

What is Acasti Pharma Inc(ACST)'s stock price today?
The current price of ACST is $2.87. The 52 week high of ACST is $3.84 and 52 week low is $1.72.
When is next earnings date of Acasti Pharma Inc(ACST)?
The next earnings date of Acasti Pharma Inc(ACST) is 2024-06-21 Est..
Does Acasti Pharma Inc(ACST) pay dividends? If so, how much?
Acasti Pharma Inc(ACST) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1